The TRIPS-Waiver is an initiative by India and South Africa to temporarily suspend patent rights in order to accelerate the global production of COVID-19 vaccines. So far more than 60 states have co-sponsored the initiative, many more are supportive of the idea. The US, Chile, Australia, Brazil, Japan, Canada, the EU, Mexico, Norway, New Zealand, Singapore and Switzerland have so far expressed scepticism. They point to existing flexibility within the TRIPS framework. The map shows the coalition of countries that are supportive of the initiative.